From the PHOSITA to the MOSITA: will “secondary considerations” save pharmaceutical patents from artificial intelligence?
D Fabris - IIC-International Review of Intellectual Property and …, 2020 - Springer
Artificial intelligence systems are being increasingly employed in pharmaceutical R&D to
develop new drugs and medical treatments. In such a scenario, the patentability of new …
develop new drugs and medical treatments. In such a scenario, the patentability of new …
Patent law in comparative context: Differences and similarities of patent law in the European Union, the United States and China
P Hutukka - … Journal of European and Comparative Law, 2023 - journals.sagepub.com
This study presents the main features of patent law in the European Union, the United States
and China, with a special focus on patentability. Each patent regime is reviewed in its …
and China, with a special focus on patentability. Each patent regime is reviewed in its …
Le brevet, norme de gestion de l'activité inventive. Nouveaux modèles pour penser une gestion des capacités inventives.
C Valibhay - 2021 - hal.science
Les brevets en tant que savoir nouveau et inventif alimentent les processus d'innovation:
l'organisation et le soutien des capacités inventives des entreprises joueraient donc un rôle …
l'organisation et le soutien des capacités inventives des entreprises joueraient donc un rôle …